Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National …

JC Weinreb, RA Rodby, J Yee, CL Wang, D Fine… - Radiology, 2021 - pubs.rsna.org
Inaugural consensus statements were developed and endorsed by the American College of
Radiology (ACR) and the National Kidney Foundation to improve and standardize the care …

Gadolinium deposition and nephrogenic systemic fibrosis: a radiologist's primer

M Mathur, JR Jones, JC Weinreb - Radiographics, 2020 - pubs.rsna.org
Gadolinium-based contrast agents (GBCAs) have an excellent safety profile. However, over
the last 2 decades, two specific concerns have surfaced. GBCAs are associated with …

KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease

PE Stevens, SB Ahmed, JJ Carrero… - Kidney …, 2024 - kidney-international.org
This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Gadolinium-based contrast agents in kidney disease: a comprehensive review and clinical practice guideline issued by the Canadian Association of Radiologists

N Schieda, JI Blaichman, AF Costa… - Canadian journal of …, 2018 - journals.sagepub.com
Purpose of review: Use of gadolinium-based contrast agents (GBCA) in renal impairment is
controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic …

Nitroxide-based macromolecular contrast agents with unprecedented transverse relaxivity and stability for magnetic resonance imaging of tumors

HVT Nguyen, Q Chen, JT Paletta, P Harvey… - ACS Central …, 2017 - ACS Publications
Metal-free magnetic resonance imaging (MRI) agents could overcome the established
toxicity associated with metal-based agents in some patient populations and enable new …

A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis

H Attari, Y Cao, TR Elmholdt, Y Zhao, MR Prince - Radiology, 2019 - pubs.rsna.org
Background Although nephrogenic systemic fibrosis (NSF) affects the use of gadolinium-
based contrast agents (GBCAs) in MRI, there continues to be limited knowledge because of …

Update on Gadolinium-Based Contrast Agent Safety, From the AJR Special Series on Contrast Media

J Starekova, A Pirasteh, SB Reeder - American Journal of …, 2024 - ajronline.org
Since its introduction more than 35 years ago, gadolinium-enhanced MRI has fundamentally
changed medical practice. Although extraordinarily safe, gadolinium-based contrast agents …

MRI safety considerations during pregnancy

M Lum, AJ Tsiouris - Clinical imaging, 2020 - Elsevier
The use of magnetic resonance imaging (MRI) during pregnancy is on the rise due its ability
to provide detailed cross-sectional anatomy without ionizing radiation. Despite the favorable …

Triply loaded nitroxide brush-arm star polymers enable metal-free millimetric tumor detection by magnetic resonance imaging

HVT Nguyen, A Detappe, NM Gallagher, H Zhang… - ACS …, 2018 - ACS Publications
Nitroxides occupy a privileged position among plausible metal-free magnetic resonance
imaging (MRI) contrast agents (CAs) due to their inherently low-toxicity profiles; …

Metal-free organo-theranostic nanosystem with high nitroxide stability and loading for image-guided targeted tumor therapy

OU Akakuru, C Xu, C Liu, Z Li, J Xing, C Pan, Y Li… - ACS …, 2021 - ACS Publications
The desire for all-organic-composed nanoparticles (NPs) of considerable biocompatibility to
simultaneously diagnose and treat cancer is undeniably interminable. Heretofore, metal …